The primary ligand-binding interaction at the GLP-1 receptor is via the putative helix of the peptide agonists

Protein Pept Lett. 2004 Feb;11(1):9-14. doi: 10.2174/0929866043478365.

Abstract

The N-terminal domain of the GLP-1 receptor binds the putative helical region of the peptide agonists, GLP-1 and exendin-4. Here we demonstrate that this interaction also determines the magnitude of a separate interaction between the N-terminus of these peptides and the receptor's core domain. Enhancing the pre-formation of the C-terminal Trp-Cage motif of exendin-4, a motif critical for high-affinity binding, results in no improvement in receptor affinity, suggesting that this motif forms after the initial peptide-receptor binding event.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Amino Acid Sequence
  • Animals
  • Binding Sites
  • Cell Line
  • Cell Membrane / drug effects
  • Cell Membrane / metabolism
  • Exenatide
  • Glucagon / chemistry*
  • Glucagon / pharmacology*
  • Glucagon-Like Peptide 1
  • Glucagon-Like Peptide-1 Receptor
  • Humans
  • Inhibitory Concentration 50
  • Ligands
  • Models, Biological
  • Molecular Sequence Data
  • Peptide Fragments / chemistry*
  • Peptide Fragments / pharmacology*
  • Peptides / chemistry*
  • Peptides / pharmacology*
  • Protein Precursors / chemistry*
  • Protein Precursors / pharmacology*
  • Rats
  • Receptors, Glucagon / agonists*
  • Receptors, Glucagon / chemistry*
  • Receptors, Glucagon / metabolism
  • Venoms / chemistry*
  • Venoms / pharmacology*

Substances

  • GLP1R protein, human
  • Glp1r protein, rat
  • Glucagon-Like Peptide-1 Receptor
  • Ligands
  • Peptide Fragments
  • Peptides
  • Protein Precursors
  • Receptors, Glucagon
  • Venoms
  • Glucagon-Like Peptide 1
  • Glucagon
  • Exenatide